Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Z Kh Akhmerzaeva"'
Autor:
E N Parovichnikova, V V Troitskaya, A N Sokolov, S N Bondarenko, O A Gavrilina, G A Baskhaeva, B V Biderman, I A Lukyanova, L A Kuz'mina, G A Klyasova, S K Kravchenko, E O Gribanova, E E Zvonkov, Z Kh Akhmerzaeva, O Yu Baranova, T S Kaporskaya, T V Ryltsova, E N Zotina, E E Zinina, O S Samoilova, K D Kaplanov, L V Gavrilova, T S Konstantinova, V A Lapin, A S Pristupa, A S Eluferyeva, T N Obukhova, I S Piskunova, I V Gal'tseva, V N Dvirnyk, M A Rusinov, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 10-17 (2017)
Aim. To analyze the efficiency and reproducibility of the ALL-2009 protocol within the Russian prospective multicenter study based on different principles of cytostatic effects (non-intensive, but continuous cytotoxic treatment and a small number of
Externí odkaz:
https://doaj.org/article/70eebaa576c444a0a015d4c4e514ab53
Autor:
E N Parovichnikova, A N Sokolov, V V Troitskaya, G A Klyasova, M A Rusinov, Z Kh Akhmerzaeva, L A Kuzmina, S N Bondarenko, O Yu Baranova, T S Kaporskaya, E N Zotina, E E Zinina, O S Samoilova, L V Gavrilova, K D Kaplanov, T S Konstantinova, V A Lapin, S K Kravchenko, E O Gribanova, E E Zvonkov, O A Gavrilina, G A Baskhaeva, G M Galstyan, T N Obukhova, I V Galtseva, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 15-24 (2016)
Aim. To analyze well-known risk factors (RFs), such as age, immunophenotype, baseline leukocytosis, enhanced lactate dehydrogenase (LDH) activity, time to achieve complete remission, a risk group, and cytogenetic abnormalities) in patients with acute
Externí odkaz:
https://doaj.org/article/b71326aeda7841e4b4714c86f887ce4f
Autor:
E N Parovichnikova, L A Kuzmina, L P Mendeleeva, G A Klyasova, V V Troitskaya, A N Sokolov, Z Kh Akhmerzaeva, S K Kravchenko, E O Gribanova, E E Zvonkov, S N Bondarenko, O Yu Baranova, T V Ryltsova, L V Gavrilova, E E Zinina, A S Pristupa, T S Kaporskaya, N V Minaeva, O S Samoilova, T S Konstantinova, V A Lapin, K D Kaplanov, I V Kryuchkova, A S Nizamutdinova, A V Klimovich, E A Borisenkova, V I Moskov, T V Gaponova, T V Obukhova, I V Galtseva, M A Rusinov, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 87, Iss 7, Pp 15-25 (2015)
Aim. To analyze the efficiency of the ALL-2009 protocol (ClinicalTrials.gov NCT01193933) in patients with T-cell leukemias, particularly the role of autologous hematopoietic stem cell transplantation (auto-HSCT) after non-myeloablative BEAM condition
Externí odkaz:
https://doaj.org/article/27ad8c10cab742848afc72addee75fae
Autor:
E. N. Parovichnikova, V. V. Troitskaya, A. N. Sokolov, Z. Kh. Akhmerzaeva, L. A. Kuzmina, L. P. Mendeleeva, G. A. Klyasova, S. K. Kravchenko, Ye. O. Gribanova, S. N. Bondarenko, O. Yu. Baranova, T. S. Kaporskaya, T. V. Ryltsova, A. S. Nizamutdinova, T. P. Zagoskina, Ye. Ye. Zinina, O. S. Samoylova, A. V. Klimovich, Ye. A. Karyakina, A. S. Yelufer’eva, L. V. Gavrilova, T. S. Konstantinova, I. Yu. Toropova, A. S. Pristupa, N. A. Vopilina, T. S. Tikunova, O. P. Skamorina, K. D. Kaplanov, T. N. Obukhova, I. V. Galtseva, M. A. Rusinov, S. M. Kulikov, V. G. Savchenko
Publikováno v:
Онкогематология, Vol 9, Iss 3, Pp 6-15 (2015)
An interim analysis of long-term treatment results for 202 patients with acute lymphoblastic leukemia (ALL), aged 15–60 years, received therapy according protocol ALL-2009 was shown. The basic principle of ALL-2009 was non-aggressive, but continued
Externí odkaz:
https://doaj.org/article/f683a655b19d4d64930aaf00d1b1b06f
Autor:
Olga Samoilova, Olga A. Gavrilina, A N Sokolov, Sergei M. Kulikov, G M Galstyan, Z Kh Akhmerzaeva, T N Obukhova, Valery G. Savchenko, L V Gavrilova, Irina V. Galtseva, M A Rusinov, Elena O. Gribanova, E E Zinina, G A Baskhaeva, E E Zvonkov, E N Zotina, Elena N. Parovichnikova, G A Klyasova, Sergey N. Bondarenko, T S Kaporskaya, O Yu Baranova, V A Lapin, Vera V. Troitskaya, K D Kaplanov, T S Konstantinova, Larisa A. Kuzmina, Kravchenko Sk
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 15-24 (2016)
to analyze well-known risk factors (RFs), such as age, immunophenotype, baseline leukocytosis, enhanced lactate dehydrogenase (LDH) activity, time to achieve complete remission, a risk group, and cytogenetic abnormalities) in patients with acute lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e75c93275a9fd03882177d377ad1535e
https://doi.org/10.17116/terarkh201688715-24
https://doi.org/10.17116/terarkh201688715-24
Autor:
Olga Samoilova, A N Sokolov, L V Gavrilova, Valery G. Savchenko, T V Gaponova, N V Minaeva, K D Kaplanov, Alexander Pristupa, T S Konstantinova, V A Lapin, E E Zvonkov, Larisa A. Kuzmina, O Yu Baranova, M A Rusinov, Kravchenko Sk, Larisa P. Mendeleeva, A V Klimovich, Sergei M. Kulikov, Sergey N. Bondarenko, Elena N. Parovichnikova, Moskov Vi, Elena O. Gribanova, T S Kaporskaya, Vera V. Troitskaya, Z Kh Akhmerzaeva, T V Obukhova, Irina V. Galtseva, I V Kryuchkova, E A Borisenkova, E E Zinina, T V Ryltsova, G A Klyasova, Alfiya Nizamutdinova
Publikováno v:
Scopus-Elsevier
Терапевтический архив, Vol 87, Iss 7, Pp 15-25 (2015)
Терапевтический архив, Vol 87, Iss 7, Pp 15-25 (2015)
To analyze the efficiency of the ALL-2009 protocol (ClinicalTrials.gov NCT01 193933) in patients with T-cell leukemias, particularly the role of autologous hematopoietic stem cell transplantation (auto-HSCT) after non-myeloablative BEAM conditioning,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ce172ab691bc6318f423d5d859512e
http://www.scopus.com/inward/record.url?eid=2-s2.0-84942602797&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84942602797&partnerID=MN8TOARS
